Profound Medical Receives Health Canada Approval for TULSA-PRO
Profound Medical Corp (NASDAQ: PROF), a medical technology Company that offers magnetic resonance guided ablation procedures, announced the approval of its TULSA-PRO® system for the ablation of low to intermediate risk organ-confined prostate cancer by Heath Canada. The Company develops innovative, customizable, incision-free and radiation free...
